Literature DB >> 14085967

CLINICAL TRIAL OF 2-GUANIDINOMETHYL (1,4) BENZODIOXAN (COMPOUND 1003).

W S PEART, M T MACMAHON.   

Abstract

Entities:  

Keywords:  ANTIHYPERTENSIVE AGENTS; DOSAGE FORMS; GUANETHIDINE; METHYLDOPA; PHARMACOLOGY; POLYTHIAZIDE; STATISTICS; TOXICOLOGIC REPORT

Mesh：

Substances：

Year:  1964        PMID： 14085967      PMCID： PMC1813365          DOI： 10.1136/bmj.1.5380.398

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  1 in total

1.  Methyldopa in the treatment of hypertension.

Authors:  R I BAYLISS; E A HARVEY-SMITH
Journal:  Lancet       Date:  1962-04-14       Impact factor: 79.321
  1 in total
  4 in total

1.  TO-DAY'S DRUGS. GUANOXAN.

Authors:  W GAISFORD
Journal:  Br Med J       Date:  1964-07-04

2.  PHARMACOLOGY OF THE ANTIHYPERTENSIVE GUANOXAN.

Authors:  M J DAVEY; H REINERT
Journal:  Br J Pharmacol Chemother       Date:  1965-02

3.  Double-blind trial of four hypotensive drugs (methyldopa and three sympatholytic agents).

Authors:  V Vejlsgaard; M Christensen; E Clausen
Journal:  Br Med J       Date:  1967-06-03

4.  [Sialoadenosis produced by drug-treatment of hypertonicity. I. Experimental studies on the effects of guanethidine (Ismelin) on the parotid glands of the rat (author's transl)].

Authors:  R Chilla; R Rieger; C Arglebe
Journal:  Arch Otorhinolaryngol       Date:  1975-07-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.